The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
Vaccine
; 27(25-26): 3439-42, 2009 May 26.
Article
in En
| MEDLINE
| ID: mdl-19200848
The morbidity and mortality rates of viral hepatitis A, B and Delta have dramatically dropped in Italy during the last decades. Thanks to the general improvements in hygiene and sanitation, hepatitis A has shifted from a high to an intermediate/low endemicity status. Vaccination against hepatitis A is recommended to people at increased risk, including travellers to endemic areas, military personnel and individuals at occupational risk. The implementation of universal anti-hepatitis B vaccination of infants and adolescents has resulted in a dramatic decline in disease burden and in the carrier rate. An additional benefit of hepatitis B vaccination is that hepatitis Delta has also substantially declined.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis D
/
Vaccination
/
Hepatitis B Vaccines
/
Hepatitis A Vaccines
/
Hepatitis A
/
Hepatitis B
Type of study:
Screening_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Vaccine
Year:
2009
Document type:
Article
Affiliation country:
Italy
Country of publication:
Netherlands